Skip to main content
SpringerLink
Log in

Cancer in Inflammatory Bowel Disease

  • Chapter
Book cover Inflammatory Bowel Disease

Part of the book series: Clinical Gastroenterology ((CG))

  • 162 Accesses

Abstract

Inflammatory bowel disease (IBD)—ulcerative colitis (UC) and Crohn’s disease (CD), inclusive—predisposes one to an increased risk of gastrointestinal malignancies. Identifying those patients at greatest risk of malignancy for cancer surveillance will allow the clinician to make the largest impact in lowering the cancer-related mortality in IBD. The approach to cancer surveillance for patients with long-standing IBD, though, is controversial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ekbom A, Helmick C. Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228–1233.

    Article  PubMed  CAS  Google Scholar 

  2. Greenstein A, Sachar D, Smith H, et al. A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 1981; 48: 2742–2745.

    Article  PubMed  CAS  Google Scholar 

  3. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: Implications for carcinogenesis and prevention. Gut 1994; 35: 950–954.

    Article  PubMed  CAS  Google Scholar 

  4. Greenstein A, Sachar D, Pucillo A, et al. Cancer in universal and left sided ulcerative colitis: Clinical and pathologic features. Mt Sinai J Med 1981; 46: 25–32.

    Google Scholar 

  5. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centers. Gut 1988; 29: 206–217.

    Article  PubMed  CAS  Google Scholar 

  6. Ekbom A, Helmick C, Zack M, et al. Increased risk of large bowel cancer in Crohn’s disease with colonic involvement. Lancet 1990; 336: 357–359.

    Article  PubMed  CAS  Google Scholar 

  7. Gillen CD, Andrews HA, Prior P, et al. Crohn’s disease and colorectal cancer. Gut 1994; 35: 651–655.

    Article  PubMed  CAS  Google Scholar 

  8. Greenstein A, Sachar D, Smith H, et al. A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 1981; 48: 2742–2745.

    Article  PubMed  CAS  Google Scholar 

  9. Weedon DD, Shorter RG, Ilstrup DM, et al. Crohn’s disease and cancer. N Engl J Med 1973; 289: 1099–1102.

    Article  PubMed  CAS  Google Scholar 

  10. Mir-Madilessi SH, Farmer RG, Easley KA, et al. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986; 58: 1569–1574.

    Article  Google Scholar 

  11. Greenstein AJ, Sugita A, Yamazaki Y. Cancer in inflammatory bowel disease. Jpn J Surg 1989; 19: 633–644.

    Article  PubMed  CAS  Google Scholar 

  12. Levin B, Lennard-Jones J, Riddell RH, et al. Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull WHO 1991; 69: 121–126.

    PubMed  CAS  Google Scholar 

  13. Choi PM, Nugent FW, Schoetz DJ Jr, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993; 105: 418–424.

    PubMed  CAS  Google Scholar 

  14. Giardello FM, Gurbuz AK, Bayless TM, et al. Colorectal cancer in ulcerative colitis: Effect of a cancer prevention strategy on survival. Gastroenterology 1993; 104: A705.

    Google Scholar 

  15. Korelitz B. Considerations of surveillance, dysplasia, and carcinoma of the colon in the management of ulcerative colitis and Crohn’s disease. Med Clin N Am 1990; 74: 189–199.

    PubMed  CAS  Google Scholar 

  16. Bernstein CN. Challenges in designing a randomized trial of surveillance colonoscopy in IBD. Inflam Bowel Dis 1998; 4: 132–141.

    CAS  Google Scholar 

  17. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of future dysplasia in ulcerative colitis. Gastroenterology 1992; 103: 1611–1620.

    PubMed  CAS  Google Scholar 

  18. Lashner BA, Hanauer SB, Silverstein MD. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med 1988; 108: 274–278.

    PubMed  CAS  Google Scholar 

  19. Lashner BA, Shapiro BD, Husain A, Goldblum JR. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer for ulcerative colitis. Am J Gastroenterol 1999; 94: 456–462.

    Article  PubMed  CAS  Google Scholar 

  20. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343: 71–74.

    Article  PubMed  CAS  Google Scholar 

  21. Connell WR, Lennard-Jones JE, Williams CB. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934–944.

    PubMed  CAS  Google Scholar 

  22. Lashner BA, Kane S, Hanauer SB, et al. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 1990; 85: 1083–1087.

    PubMed  CAS  Google Scholar 

  23. Bernstein CN, Weinstein WM, Levine DS, et al. Physicians perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995; 90: 2106–2114.

    PubMed  CAS  Google Scholar 

  24. Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80: 366–374.

    PubMed  CAS  Google Scholar 

  25. Butt JH, Konishi F, Morson PC, et al. Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis. Dig Dis Sci 1983; 28: 18–26.

    Article  PubMed  CAS  Google Scholar 

  26. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standard classification with provisional clinical applications. Hum Pathol 1983; 14: 931–968.

    Article  PubMed  CAS  Google Scholar 

  27. Engelsgjred M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999; 117: 1288–1294.

    Article  Google Scholar 

  28. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999; 117: 1295–1300.

    Article  PubMed  CAS  Google Scholar 

  29. Lashner BA, Turner BC, Bostwick DG, et al. Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci 1990; 35: 349–352.

    Article  PubMed  CAS  Google Scholar 

  30. Hamilton SR. Colorectal carcinoma in patients with Crohn’s disease. Gastroenterology 1985; 89: 398–407.

    PubMed  CAS  Google Scholar 

  31. Cooper DJ, Weinstein MA, Korelitz BI. Complications of Crohn’s disease predisposing to dysplasia and cancer of the intestinal tract: Consideration of a surveillance program. J Clin Gastroenterol 1984; 6: 217–224.

    Article  PubMed  CAS  Google Scholar 

  32. Craft CF, Mendelsohn G, Cooper HS, et al. Colonic “precancer” in Crohn’s disease. Gastroenterology 1981; 80: 578–584.

    PubMed  CAS  Google Scholar 

  33. Warren R, Barwick KW. Crohn’s colitis with carcinoma and dysplasia. Report of a case and review of 100 small and large bowel resections for Crohn’s disease to detect the incidence of dysplasia. Am J Surg Pathol 1983; 7: 151–159.

    Article  PubMed  CAS  Google Scholar 

  34. Mittal VK, Bodzin JH. Primary malignant tumors of the small intestine. Am J Surg 1980; 140: 396–399.

    Article  PubMed  CAS  Google Scholar 

  35. Barclay THC, Shapira DV. Malignant tumors of the small intestine. Cancer 1983; 511: 878–881.

    Article  Google Scholar 

  36. Johnson AM, Harman PK, Hanks JB. Primary small bowel malignancies. Am Surg 1985; 51: 31–36.

    PubMed  CAS  Google Scholar 

  37. DiSario JA, Burt RW, Vargas H, et al. Small bowel cancer; epidemiological and clinical characteristics from the population-based registry. Am J Gastroenterol 1994; 89: 699–701.

    PubMed  CAS  Google Scholar 

  38. Seifert E, Schulte F, Stolte M. Adenoma and carcinoma of the duodenum and papilla of Vater: a clinicopathologic study. Am J Gastroenterol 1992; 87: 37–42.

    PubMed  CAS  Google Scholar 

  39. Chow JS, Chen CC, Ahsan H, et al. A population-based study of the incidence of malignant small bowel tumors. SEER, 1973–1990. IntJEpidemiol 1996; 25: 722–728.

    Article  PubMed  CAS  Google Scholar 

  40. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5–27.

    Article  PubMed  CAS  Google Scholar 

  41. Greenstein AJ, Sachar DB, Smith H, et al. Pattern’s of neoplasia in Crohn’s disease and ulcerative colitis. Cancer 1980; 46: 403–407.

    Article  PubMed  CAS  Google Scholar 

  42. Sigel JE, Petras RE, Lashner BA, et al. Intestinal adenocarcinoma in Crohn’s disease. Am J Surg Path 1999; 23: 651–655.

    Article  PubMed  CAS  Google Scholar 

  43. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn’s-associated adenocarcinomas of the small intestine. Gastroenterology 1997; 113: 127–135.

    Article  PubMed  CAS  Google Scholar 

  44. Korelitz BI. Carcinoma of the intestinal tract in Crohn’s disease: Results of a survey conducted by the National Foundation for Ileitis and Colitis. Am J Gastroenterol 1983; 8: 44–46.

    Google Scholar 

  45. Binder V. Epidemiology, course and socio-economic influence of inflammatory bowel disease. Schweiz Med Wschr 1988; 118: 738–742.

    PubMed  CAS  Google Scholar 

  46. Gollop JH, Phillips SF, Melton LJ, et al. Epidemiological aspects of Crohn’s disease: A population based study in Olmsted County, Minnesota. Gut 1988; 29: 49–56.

    Article  PubMed  CAS  Google Scholar 

  47. Olsson R, Danilesson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319–1323.

    PubMed  CAS  Google Scholar 

  48. Mir-Madjlessi SH, Farmer RG, Sivak MV. Bile duct carcinoma in patients with ulcerative colitis. Dig Dis Sci 1987; 32: 145–154.

    Article  PubMed  CAS  Google Scholar 

  49. Marchesa P, Lashner BA, Lavery IC, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1997; 92: 1285–1288.

    PubMed  CAS  Google Scholar 

  50. Loftus EV, Sandborn WJ, Tremaine WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996; 110: 432–440.

    Article  PubMed  Google Scholar 

  51. Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 1643–1649.

    Article  PubMed  CAS  Google Scholar 

  52. Kyle J. Carcinoma of the esophagus in patients with Crohn’s disease. J R Coll Surg (Edinb) 1991; 36: 125–126.

    CAS  Google Scholar 

  53. Freedman PG, Dietrich ST, Balthazar EJ. Crohn’s disease of the esophagus: a case report and review of the literature. Am J Gastroenterol 1984; 79: 835–858.

    PubMed  CAS  Google Scholar 

  54. Gyde SN, Prior P, Macartney JC, et al. Malignancy in Crohn’s disease. Gut 1980; 21: 1024–1029.

    Article  PubMed  CAS  Google Scholar 

  55. Glick SN. Gastric carcinoma in patients with Crohn’s disease: report of four cases. AJR 1991; 157: 311–14.

    Article  PubMed  CAS  Google Scholar 

  56. Buchman P, Allan RN, Thompson H, et al. Carcinoma in a rectovaginal fistula in a patient with Crohn’s disease. AM J Surg 1980; 140: 462–463.

    Article  Google Scholar 

  57. Church JM, Weakley FL, Fazio VW, et al. The relationship between fistulas in Crohn’s disease and associated carcinoma. Dis Colon Rectum 1985; 28: 361–366.

    Article  PubMed  CAS  Google Scholar 

  58. Greenstein AJ, Balasubramanian S, Harpaz N, Rizwan M, Sachar DB. Carcinoid turom and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol 1997; 92: 682–685.

    PubMed  CAS  Google Scholar 

  59. Hsu EY, Feldman JM, Lichtenstein GR. Ileal carcinoid tumors stimulating Crohn’s disease: incidence among 176 consecutive cases of ileal carcinoid. Am J Gastroenterol 1997; 92: 206–205.

    Google Scholar 

  60. Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249–1252.

    Article  PubMed  CAS  Google Scholar 

  61. Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999; 94: 3248–3253.

    Article  PubMed  CAS  Google Scholar 

  62. Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F. The relationship between infliximab treatment and lymphoma in Crohn’s disease. Gastroenterology 1999; 117: 1433–1437.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. William M. Bauer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bret A. Lashner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Gastroenterology, Department of Medicine, The University of Chicago Medical Center, Chicago, IL, USA

    Russell D. Cohen MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bauer, W.M., Lashner, B.A. (2003). Cancer in Inflammatory Bowel Disease. In: Cohen, R.D. (eds) Inflammatory Bowel Disease. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-311-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-311-8_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5465-0

  • Online ISBN: 978-1-59259-311-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation